Results 11 to 20 of about 825,494 (348)
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. [PDF]
PLoS ONE, 2011 Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in ...
Amit Dutt +11 more
doaj +14 more sources
the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma
مجلة كلية الطب, 2023 Background Stathmin1 (also known as metablastin) is a major microtubule-depolymerizing protein that involved in cell cycle progression and cell motility.
Nadhema Bahaa Hussein Wetwet +3 more
doaj +1 more source
Lung Cancer: A Literature Review
Jurnal Respirasi, 2023 Lung cancer is a cancer whose onset starts in the lungs where there is an abnormal cell growth that is very fast and uncontrolled. The abnormal cell growth is triggered by deoxyribonucleic acid (DNA) damage, including deletions in the DNA section ...
Yan Efrata Sembiring +8 more
doaj +1 more source
Thoracic Cancer, 2021 Immune checkpoint inhibitors with chemotherapy have been shown to exhibit remarkable efficacy for advanced non‐small‐cell lung carcinoma and are under investigation as an induction therapy.
Shunichi Saito +6 more
doaj +1 more source
The Journal of Association of Chest Physicians, 2023 Spindle cell carcinoma is one of the histological variants of pulmonary sarcomatoid carcinoma. It is a rare, poorly differentiated, highly malignant, and rapidly growing non-small cell carcinoma of the lung.
Pratap Upadhya +3 more
doaj +1 more source
Respiratory Medicine Case Reports, 2020 Pulmonary pleomorphic carcinoma (PPC) is a poorly differentiated non-small cell lung carcinoma, including squamous cell carcinoma, adenocarcinoma, or undifferentiated non-small cell lung carcinoma with at least 10% spindle and/or giant cells.
Jae-Han Jeong +3 more
doaj +1 more source
Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
Clinical Case Reports, 2022 The syndrome of Leser‐Trélat (LT) is a rare paraneoplastic syndrome. However, patients presenting with the sign of Leser‐Trélat should be considered to harbor an occult malignancy or a progressive tumor disease until “proven” otherwise.
Rim Khemakhem +4 more
doaj +1 more source
pTNM System in Non Small Cell Lung Carcinoma
Indonesian Journal of Cancer, 2008 Prognosis karsinoma paru berhubungan dengan berbagai macam faktor, antara lain : usia, jenis kelamin, ukuran tumor, staging, jenis sel dan derajat diferensiasi, invasi kepembuluh darah, dinding dada, efusi pleura, adanya jaringan ikat, keterlibatan KGB ...
Heriawaty Hidajat +5 more
doaj +1 more source
Predictive testing in non-small cell lung carcinoma
Klinicka onkologie, 2021 Predictive testing is a crucial part of the complete diagnostic process of non-small cell lung cancer (NSCLC) and a necessary requirement in order to determine proper course of treatment. However, the possibilities of testing and the spectrum of examined markers are quickly evolving as a result of the progress in diagnostic and therapeutic ...
P, Dundr +4 more
openaire +2 more sources
A Case of Bowen’s Disease and Small-Cell Lung Carcinoma: Long-Term Consequences of Chronic Arsenic Exposure in Chinese Traditional Medicine [PDF]
, 2004 Chronic arsenic toxicity occurs primarily through inadvertent ingestion of contaminated water and food or occupational exposure, but it can also occur through medicinal ingestion.
Castren K +8 more
core +2 more sources